MARKET

CERT

CERT

Certara, Inc.
NASDAQ
8.20
+0.07
+0.86%
After Hours: 8.20 0 0.00% 19:34 08/07 EDT
OPEN
8.13
PREV CLOSE
8.13
HIGH
8.29
LOW
8.06
VOLUME
2.30M
TURNOVER
--
52 WEEK HIGH
13.88
52 WEEK LOW
4.450
MARKET CAP
1.25B
P/E (TTM)
-18.5899
1D
5D
1M
3M
1Y
5Y
1D
Certara Corrects EBITDA Disclosure in Earnings Presentation
TipRanks · 12h ago
Certara (CERT) Could Be 9% Undervalued On Earnings Guidance And Buyback News
Simply Wall St · 16h ago
Certara price target raised to $7 from $6 at Baird
TipRanks · 2d ago
Certara price target lowered to $9 from $10 at Morgan Stanley
TipRanks · 2d ago
Certara: Hold Rating Maintained as Turnaround Progress Offsets Near-Term Pressures; Price Target Trimmed from $10 to $9
TipRanks · 2d ago
BMO Capital Sticks to Its Hold Rating for Certara (CERT)
TipRanks · 2d ago
Barclays Maintains Equal-Weight on Certara, Raises Price Target to $7.5
Benzinga · 2d ago
Certara price target raised to $7.50 from $6.50 at Barclays
TipRanks · 2d ago
More
About CERT
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.

Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERT stock methods without spending real money on the virtual paper trading platform.